NanoVibronix, Inc. (NASDAQ:NAOV – Get Free Report) was the target of a significant decline in short interest in June. As of June 15th, there was short interest totalling 34,700 shares, a decline of 17.4% from the May 31st total of 42,000 shares. Based on an average trading volume of 38,800 shares, the short-interest ratio is presently 0.9 days. Currently, 1.3% of the company’s stock are short sold.
Institutional Investors Weigh In On NanoVibronix
A hedge fund recently bought a new stake in NanoVibronix stock. Armistice Capital LLC acquired a new position in shares of NanoVibronix, Inc. (NASDAQ:NAOV – Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 29,023 shares of the company’s stock, valued at approximately $57,000. Armistice Capital LLC owned about 1.75% of NanoVibronix at the end of the most recent quarter. Hedge funds and other institutional investors own 16.39% of the company’s stock.
NanoVibronix Stock Down 1.8 %
NASDAQ NAOV traded down $0.01 during trading hours on Friday, hitting $0.70. 46,189 shares of the company were exchanged, compared to its average volume of 33,041. The firm has a market cap of $1.95 million, a price-to-earnings ratio of -0.41 and a beta of 1.45. The company has a 50 day moving average of $0.76 and a two-hundred day moving average of $0.90. NanoVibronix has a 52-week low of $0.68 and a 52-week high of $4.23.
NanoVibronix Company Profile
NanoVibronix, Inc, through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use.
Read More
- Five stocks we like better than NanoVibronix
- How to Effectively Use the MarketBeat Ratings Screener
- Upwork Stock’s Outlook: Numbers Solid Despite Gen-AI Challenges
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- What’s Behind Walgreens Stock Plunge: What Investors Can Do Next
- What is the S&P 500 and How It is Distinct from Other Indexes
- MarketBeat Week in Review – 6/24 – 6/28
Receive News & Ratings for NanoVibronix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoVibronix and related companies with MarketBeat.com's FREE daily email newsletter.